Toxicology
Acetaminophen restriction curbs new emergency liver transplants in the U.K.
Published in Hepatitis Weekly, October 27th, 2003
"Acute liver failure (ALF) is a rare condition in the United Kingdom. Comprehensive supportive intensive care of extra-hepatic organ failure and the early recognition of and use of transplantation for those who will not survive form the cornerstone of its management. Over the last 30 years there has been a reduction in the proportion of cases resulting from viral and seronegative hepatitis, and a progressive rise in those resulting from severe acetaminophen-induced hepatotoxicity," scientists in England report.
"The latter cases mostly result from deliberate self-poisoning...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-10-27)
More Articles from Hepatitis Weekly
- Neuroscience
MARS alleviates neurological progression in liver disease-related coma - Transplantation
Interferon therapy prior to liver transplant curbs hepatitis C recurrence - Diet and Nutrition
Creatine supplementation causes liver inflammation in mice but not rats - Liver Cirrhosis
Suppression subtractive hybridization characterizes the genetics of cirrhosis - Virology
The 5' untranslated region of GB virus C highlights genotypic differences - AIDS Research
U.S.-Russian initiative to intensify cooperation in fight against disease - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
